Rifabutin for treating pulmonary tuberculosis
is a topic covered in the Evidence-Based Medicine Guidelines
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
"Rifabutin for Treating Pulmonary Tuberculosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454780/all/Rifabutin_for_treating_pulmonary_tuberculosis.
Rifabutin for treating pulmonary tuberculosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454780/all/Rifabutin_for_treating_pulmonary_tuberculosis. Accessed October 23, 2019.
Rifabutin for treating pulmonary tuberculosis. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/454780/all/Rifabutin_for_treating_pulmonary_tuberculosis
Rifabutin for Treating Pulmonary Tuberculosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 October 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454780/all/Rifabutin_for_treating_pulmonary_tuberculosis.
TY - ELEC
T1 - Rifabutin for treating pulmonary tuberculosis
ID - 454780
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454780/all/Rifabutin_for_treating_pulmonary_tuberculosis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine